However, extensive in vitro and in vivo studies, coupled with structure–activity relationship analysis, are needed to further support this hypothesis, using biochemical assays on both CA5 isoforms and animal models of obesity and dyslipidemia. This evidence concerns the gene CA5A and obesity due to melanocortin 4 receptor deficiency.